Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Warner-Lambert prepares naphthyridinone kinase and cell proliferation inhibitors

April 13, 1999

Xenova presents novel topoisomerase inhibitor at AACR

April 13, 1999

Multiple mechanisms of cytotoxic activity described for FR-901228

April 13, 1999

Pharmacokinetic evaluation of CDK inhibitor indicates need for short dosing interval

April 13, 1999

Calydon presents preclinical data on novel ARCA compound for prostate tumors

April 12, 1999

Design, preclinical toxicity of VNP-20009, a genetically modified Salmonella strain for solid tumors

April 12, 1999

Aplidine: mechanism of antitumor activity is explored

April 12, 1999

Preclinical results support clinical evaluation of BCH-4556 for prostate cancer

April 12, 1999

Synthetic peptide from Demegen selectively targets cancerous prostate cells in vitro

April 12, 1999

AACR presentation for BN-80915, an improved camptothecin analogue

April 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...